financetom
Business
financetom
/
Business
/
Pine Labs launches AllTap App for small merchants to accept contactless payments via their smartphones
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pine Labs launches AllTap App for small merchants to accept contactless payments via their smartphones
Jan 27, 2021 7:27 AM

Merchant commerce platform Pine Labs has today launched an AllTap app with am aim to accelerate digital payments adoption in India. Specially designed for small merchants, this free to download app can enable the user to immediately start accepting digital payments without the need of any additional hardware. As of now, the app Pine Labs AllTap app is available on Google Play Store

How does it work?

All you need is an NFC-enabled smartphone. Coupled with the ‘tap and pay’ feature within the AllTap, merchants can convert their smartphone into a payment acceptance device. Pine Labs claims that this can activated within minutes and merchants can avail a host of other additional features such as converting a transaction into Pay Later EMIs.

Amrish Rau, CEO, Pine Labs said, “We heard from small merchants, taxi drivers, self-employed individuals, tuition-givers, and several other solopreneurs, who wanted a simple digital payments acceptance solution.” He added, “AllTapcomes with a cutting-edge contactless payments technology and requires no additional hardware for merchants to start accepting digital payments. Their NFC-enabled smartphone is now a payments acceptance device.”

Pine Labs’ app is certified by the PCI Security Standards Council (PCI SSC), RuPay, Visa, Mastercard and Amex. The team added that with this app merchant can now switch to contactless digital payment, accept digital payments acceptance during door-step delivery, reduce the checkout time delays through quick tap-and-go payments.

Sanjeev Kumar, CTO, Pine Labs said, “With AllTap, we are offering merchants a robust PCI-compliant Contactless Payments on COTS (CPoC) solution. This ensures all tap and pay transactions are fully secure. Our PCI-CPoC listing underwent an extensive audit and certification from PCI SSC and leading networks Visa, RuPay, Mastercard, and Amex.”

With a presence in Asia and the Middle East, Pine Labs serves large, mid-sized and small merchants. Incorporated in Singapore, Pine Labs’ key investors include Actis Capital, Mastercard, PayPal, Sequoia India, and Temasek.

First Published:Jan 27, 2021 4:27 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck & Co Unusual Options Activity For July 15
Merck & Co Unusual Options Activity For July 15
Jul 15, 2025
Deep-pocketed investors have adopted a bearish approach towards Merck & Co ( MRK ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MRK usually suggests something big is about to happen. We gleaned this...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
BioXcel Therapeutics Gets Patent Allowance for Targeted Use of Igalmi in Bipolar, Schizophrenia Patients
BioXcel Therapeutics Gets Patent Allowance for Targeted Use of Igalmi in Bipolar, Schizophrenia Patients
Jul 15, 2025
11:00 AM EDT, 07/15/2025 (MT Newswires) -- BioXcel Therapeutics ( BTAI ) said Tuesday in a regulatory filing that the US Patent and Trademark Office allowed a new patent related to a single dose of up to 120 micrograms of dexmedetomidine, delivered as an oromucosal formulation. The dose is for treating acute agitation in patients with schizophrenia or bipolar disorder...
SPY Parent State Street's Q2 Beat Overshadowed By Rising Costs, Dwindling Net Interest Income
SPY Parent State Street's Q2 Beat Overshadowed By Rising Costs, Dwindling Net Interest Income
Jul 15, 2025
State Street Corporation ( STT ) shares are trading lower on Tuesday after reporting second-quarter results. The company reported adjusted earnings per share of $2.53, beating the analyst consensus estimate of $2.37. Quarterly sales of $3.448 billion (+8% year over year) outpaced the Street view of $3.347 billion. Investment Management AUM as of quarter-end increased 17% to $5.1 trillion, mainly...
Copyright 2023-2026 - www.financetom.com All Rights Reserved